NCT02113683

Validation of MMS Test for Cancer Monitoring

Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: MedInnovation GmbH · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Conditions

• Colo-rectal Cancer
• Stomach Cancer
• Melanoma
• Sarcoma

Timeline

• Start date: 2014-05-01
• Primary completion: 2018-06-20
• Completion: 2018-06-20
• First posted: 2014-04-15
• Last updated: 2018-06-21

Locations

1 site across 1 country: Germany